Cardiff Oncology (Germany) Probability of Future Stock Price Finishing Over 2.58
| XE7C Stock | EUR 3.15 0.08 2.61% |
Cardiff |
Cardiff Oncology Target Price Odds to finish over 2.58
The tendency of Cardiff Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above € 2.58 in 90 days |
| 3.15 | 90 days | 2.58 | about 74.13 |
Based on a normal probability distribution, the odds of Cardiff Oncology to stay above € 2.58 in 90 days from now is about 74.13 (This Cardiff Oncology probability density function shows the probability of Cardiff Stock to fall within a particular range of prices over 90 days) . Probability of Cardiff Oncology price to stay between € 2.58 and its current price of €3.15 at the end of the 90-day period is about 14.75 .
Assuming the 90 days trading horizon the stock has the beta coefficient of 1.01 . This entails Cardiff Oncology market returns are reactive to returns on the market. As the market goes up or down, Cardiff Oncology is expected to follow. Moreover Cardiff Oncology has an alpha of 1.6236, implying that it can generate a 1.62 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Cardiff Oncology Price Density |
| Price |
Predictive Modules for Cardiff Oncology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cardiff Oncology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cardiff Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cardiff Oncology Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cardiff Oncology is not an exception. The market had few large corrections towards the Cardiff Oncology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cardiff Oncology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cardiff Oncology within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 1.62 | |
β | Beta against NYSE Composite | 1.01 | |
σ | Overall volatility | 1.39 | |
Ir | Information ratio | 0.16 |
Cardiff Oncology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cardiff Oncology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cardiff Oncology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cardiff Oncology is way too risky over 90 days horizon | |
| Cardiff Oncology appears to be risky and price may revert if volatility continues | |
| Cardiff Oncology has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 359 K. Net Loss for the year was (28.29 M) with loss before overhead, payroll, taxes, and interest of (17.02 M). | |
| Cardiff Oncology has accumulated about 140.05 M in cash with (23.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.54, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Cardiff Oncology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cardiff Stock often depends not only on the future outlook of the current and potential Cardiff Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cardiff Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 42 M |
Cardiff Oncology Technical Analysis
Cardiff Oncology's future price can be derived by breaking down and analyzing its technical indicators over time. Cardiff Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cardiff Oncology. In general, you should focus on analyzing Cardiff Stock price patterns and their correlations with different microeconomic environments and drivers.
Cardiff Oncology Predictive Forecast Models
Cardiff Oncology's time-series forecasting models is one of many Cardiff Oncology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cardiff Oncology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Cardiff Oncology
Checking the ongoing alerts about Cardiff Oncology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cardiff Oncology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Cardiff Oncology is way too risky over 90 days horizon | |
| Cardiff Oncology appears to be risky and price may revert if volatility continues | |
| Cardiff Oncology has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 359 K. Net Loss for the year was (28.29 M) with loss before overhead, payroll, taxes, and interest of (17.02 M). | |
| Cardiff Oncology has accumulated about 140.05 M in cash with (23.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.54, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Cardiff Oncology Backtesting, Cardiff Oncology Valuation, Cardiff Oncology Correlation, Cardiff Oncology Hype Analysis, Cardiff Oncology Volatility, Cardiff Oncology History as well as Cardiff Oncology Performance. For more detail on how to invest in Cardiff Stock please use our How to Invest in Cardiff Oncology guide.Note that the Cardiff Oncology information on this page should be used as a complementary analysis to other Cardiff Oncology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Cardiff Stock analysis
When running Cardiff Oncology's price analysis, check to measure Cardiff Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardiff Oncology is operating at the current time. Most of Cardiff Oncology's value examination focuses on studying past and present price action to predict the probability of Cardiff Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardiff Oncology's price. Additionally, you may evaluate how the addition of Cardiff Oncology to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |